Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Suspended × Neoplasms × Clear all

Phase

Phase 1 11 Phase NA 8 Phase 1/2 8 Phase 2 3 Phase 3 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Completed 34 Recruiting 20 Unknown 13 Terminated 9 Withdrawn 7 Not yet recruiting 7 Active not recruiting 4 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ototoxicity 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Mycosis Fungoides 1 Lymphoma, B-Cell 1 Hepatoblastoma 1 Depression 1 Colorectal Neoplasms 1 Anxiety Disorders 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06213298 2026-02-11

Effect of Kava on Anxiety and Stress in Cancer Survivors

Masonic Cancer Center, University of Minnesota

Phase EARLY_PHASE1 Suspended

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡